Inicio › Cáncer de seno › Nueva Jersey › Newark
Ensayos clínicos de Cáncer de seno en Newark, NJ
18 estudios para Cáncer de seno buscan participantes en centros de Newark y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
ReclutandoFase 3
- Summit Health, Florham Park · A 12 mi de distancia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Morristown Medical Center, Morristown · A 17 mi de distancia
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
ReclutandoFase 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
ReclutandoFase 1/2
- Summit Medical Group, Florham Park · A 12 mi de distancia
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ReclutandoFase 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · A 9 mi de distancia
- Summit Medical Group PA, Florham Park · A 12 mi de distancia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ReclutandoFase 3
- Summit Medical Group, Florham Park · A 12 mi de distancia
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
ReclutandoFase 3
- Summit Medical Group, Florham Park · A 12 mi de distancia
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
ReclutandoEstudio observacional
- Summit Medical Group, Florham Park · A 12 mi de distancia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ReclutandoFase 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · A 9 mi de distancia
- Morristown Medical Center, Morristown · A 17 mi de distancia
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
ReclutandoFase 2
- GSK Investigational Site, Morristown · A 17 mi de distancia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ReclutandoFase 3
- Morristown Medical Center, Morristown · A 17 mi de distancia
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Reclutando
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Morristown Medical Center, Morristown · A 17 mi de distancia
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Reclutando
- Summit Health, Florham Park · A 12 mi de distancia
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
ReclutandoFase 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · A 4 mi de distancia
- Cooperman Barnabas Medical Center, Livingston · A 9 mi de distancia
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
ReclutandoFase 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
ReclutandoFase 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- y 2 más
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
ReclutandoFase 3
- Morristown Medical Center, Morristown · A 17 mi de distancia
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Newark
- Traumatismo de la médula espinal13 estudios
- Cáncer de pulmón de células no pequeñas13 estudios
- Leucemia mielógena aguda12 estudios
- Fallo cardíaco10 estudios
- Cáncer metastásico10 estudios
- Enfermedad cardiovascular9 estudios
- Cáncer de páncreas9 estudios
- Melanoma8 estudios
- Cáncer (todos los tipos)7 estudios
- Cáncer de pulmón7 estudios
- Enfermedad de Crohn7 estudios
- Estenosis de la válvula aórtica6 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.